The drug company Gilead Sciences won on all counts in its legal battle with the US government over control of patents for antiviral drugs for the pre-exposure prophylaxis of HIV infection. The six member jury needed little time to return its verdict in a Delaware courtroom on 9 May.
Scientists at the US Centers for Disease …